Discover how The US Oncology Network leverages AI to reduce provider burden, extract clinical data and improve patient outcomes.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportIn the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Read Time
3.5 minutes
Dr. Andrew McKenzie, PhD, vice president of personalized medicine at Sarah Cannon Research Institute (SCRI), shares how ²ÝÝ®ÊÓÆµ is helping lead the precision medicine revolution through data-driven insights and purpose-driven collaboration with biopharma.
About Always Advancing:
From navigating the stages of research and development and engaging diverse populations in clinical trials to enabling patient access to prescribed therapies and beyond, the healthcare landscape has never been more complex or more promising for improving the lives of patients. Our Always Advancing series shares how we help our biopharma partners bridge the divide between today’s challenges and tomorrow’s breakthroughs so more patients can get the care they need.
Discover how The US Oncology Network leverages AI to reduce provider burden, extract clinical data and improve patient outcomes.
Discover how The US Oncology Network leverages AI to reduce provider burden, extract clinical data and improve patient outcomes.
At Biologics by ²ÝÝ®ÊÓÆµ, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
At Biologics by ²ÝÝ®ÊÓÆµ, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
How ²ÝÝ®ÊÓÆµ connects biopharma, providers and patients to deliver precision oncology at scale through integrated logistics, specialty pharmacy and high‑touch support.
How ²ÝÝ®ÊÓÆµ connects biopharma, providers and patients to deliver precision oncology at scale through integrated logistics, specialty pharmacy and high‑touch support.
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
How Shenandoah Oncology became a blueprint for compassion and turned patient feedback into a lifeline.
How Shenandoah Oncology became a blueprint for compassion and turned patient feedback into a lifeline.
How community oncology clinics are helping break down barriers to care.
How community oncology clinics are helping break down barriers to care.
How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using ²ÝÝ®ÊÓÆµ Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
Using ²ÝÝ®ÊÓÆµ Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.